![Jing Ji](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jing Ji
Technik-/Wissenschafts-/F&E-Leiter bei
ABBISKO CAYMAN LIMITED
Vermögen: 6 Mio $ am 31.05.2026
Profil
Jing Ji is Director & Chief Medical Officer at Abbisko Cayman Ltd. since 2025.
Former positions include Senior VP-Medical & Clinical Development at Shanghai Lianbio Development Co., Ltd. from 2020 to 2021, Vice President at AstraZeneca PLC from 2015 to 2020, Head-Medical Affairs at GSK Plc from 2006 to 2010, Manager-Clinical Development at Sanofi from 2003 to 2005, and Manager-Clinical Research at Merck Sharp & Dohme (China) Ltd. from 1997 to 2003.
Education includes undergraduate and graduate degrees from Fudan University in 1993 and 1995, and undergraduate and graduate degrees from Shanghai Second Medical University in 1993 and 1995.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 04.06.2026 | 5.039.068 ( 0,7 % ) | 6 Mio $ | 31.05.2026 |
Aktive Positionen von Jing Ji
| Unternehmen | Position | Beginn |
|---|---|---|
| ABBISKO CAYMAN LIMITED | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2021 |
Ehemalige bekannte Positionen von Jing Ji
| Unternehmen | Position | Ende |
|---|---|---|
Shanghai Lianbio Development Co., Ltd.
 Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures paradigm-shifting medicines to patients | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 01.05.2020 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2010 |
| SANOFI | Corporate Officer/Principal | 01.09.2005 |
Merck Sharp & Dohme (China) Ltd.
 Merck Sharp & Dohme (China) Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a research-intensive biopharmaceutical company for medicines, vaccines and animal health products | Corporate Officer/Principal | 01.03.2003 |
Ausbildung von Jing Ji
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
84
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
GSK Plc
 GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Fudan University
 Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shanghai Second Medical University
 Shanghai Second Medical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Sharp & Dohme (China) Ltd.
Merck Sharp & Dohme (China) Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a research-intensive biopharmaceutical company for medicines, vaccines and animal health products | Commercial Services |
Abbisko Cayman Ltd.
 Abbisko Cayman Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company dedicated to the discovery and development of small molecule oncology therapies | Health Technology |
Shanghai Lianbio Development Co., Ltd.
Shanghai Lianbio Development Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures paradigm-shifting medicines to patients | Health Technology |
